BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3597147)

  • 1. Prognostic variables in endometrial carcinoma.
    Poulsen MG; Roberts SJ
    Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1043-52. PubMed ID: 3597147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
    Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer.
    Hanson MB; van Nagell JR; Powell DE; Donaldson ES; Gallion H; Merhige M; Pavlik EJ
    Cancer; 1985 Apr; 55(8):1753-7. PubMed ID: 3978563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of stage II endometrial adenocarcinoma.
    Trimble EL; Jones HW
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):323-6. PubMed ID: 3347415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of stage II endometrial carcinoma.
    Boothby RA; Carlson JA; Neiman W; Rubin MM; Morgan MA; Schultz D; Mikuta JJ
    Gynecol Oncol; 1989 May; 33(2):204-8. PubMed ID: 2495242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial carcinoma stage I--comparison of two different treatment regimes--evaluation of risk factors and its influence on prognosis; suggested step by step treatment protocol.
    Baram A; Figer A; Inbar M; Levy E; Peyser MR; Stein Y
    Gynecol Oncol; 1985 Nov; 22(3):294-301. PubMed ID: 4065704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors.
    Mandell LR; Nori D; Hilaris B
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1103-9. PubMed ID: 3997592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment procedure for stage I endometrial adenocarcinoma.
    Wolff JP; Pejovic MH; Michel G; Gerbaulet A; Prade M; George M
    Gynecol Oncol; 1986 Jan; 23(1):51-8. PubMed ID: 3943752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage II endometrial carcinoma treated with external-beam radiotherapy, intracavitary application of cesium, and surgery.
    Podczaski ES; Kaminski P; Manetta A; Louk D; Andrews C; Larson J; DeGeest K; Mortel R
    Gynecol Oncol; 1989 Nov; 35(2):251-4. PubMed ID: 2807019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
    Greer BE; Koh WJ; Abu-Rustum N; Bookman MA; Bristow RE; Campos SM; Cho KR; Copeland L; Crispens MA; Eifel PJ; Huh WK; Jaggernauth W; Kapp DS; Kavanagh JJ; Lurain JR; Morgan M; Morgan RJ; Powell CB; Remmenga SW; Reynolds RK; Alvarez Secord A; Small W; Teng N
    J Natl Compr Canc Netw; 2009 May; 7(5):498-531. PubMed ID: 19460278
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of endometrial adenocarcinoma with cervical involvement.
    Rubin SC; Hoskins WJ; Saigo PE; Nori D; Mychalczak B; Chapman D; Lewis JL
    Gynecol Oncol; 1992 Jun; 45(3):294-8. PubMed ID: 1612507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage II carcinoma of the endometrium: results of therapy and prognostic factors.
    Grigsby PW; Perez CA; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1915-23. PubMed ID: 4055452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma.
    Komaki R; Cox JD; Hartz AJ; Wilson JF; Mattingly R
    Cancer; 1986 Aug; 58(4):873-9. PubMed ID: 3719554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic aspects of endometrial carcinoma.
    Svigos JM; Cox LW; Kirkland JA; Harvey ND
    Aust N Z J Obstet Gynaecol; 1978 Nov; 18(4):253-8. PubMed ID: 284770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma.
    Higgins RV; van Nagell JR; Horn EJ; Roberts SL; Donaldson ES; Gallion HH; DePriest PD; Powell DE; Kryscio RJ
    Cancer; 1991 Sep; 68(6):1261-4. PubMed ID: 1873779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965.
    Homesley HD; Boronow RC; Lewis JL
    Obstet Gynecol; 1976 Jan; 47(1):100-5. PubMed ID: 1246374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.